Built by PJ Zonis · SideGuy Solutions
Operator-honest, North County San Diego. No retainer, no sales call — a real human who'll tell you straight which of this you actually need.
💬 Text PJ · 858-461-8054 · 📤 Share this
Software can be Part 11 capable. It can't be Part 11 compliant for you — that's a property of how you validate, configure, and operate it. The gap between those two words is where FDA findings live.
"Part 11 software" provides the features — audit trails, access controls, compliant e-signatures, record retention. eTMF, LIMS, eQMS, CTMS, MES.
But the vendor can't make you compliant. The FDA holds the regulated company accountable, so you still own Computer System Validation (CSV), the SOPs for how it's used, and the evidence the controls are on and working.
So "Part 11 compliant software" really means "Part 11 capable." Buy for the capability; budget for the validation. That's the half most vendors don't say out loud.
The control, what it means, and whether the software or you owns it.
| Requirement | What it means | Software vs you |
|---|---|---|
| Validation (CSV) | System proven to perform accurately, reliably, consistently for its intended use. | Mostly YOU — vendor may supply validation kits, but you validate in your environment. |
| Audit trails | Secure, computer-generated, time-stamped log of who did what, when — without obscuring prior entries. | Software provides; you confirm it's enabled + reviewed. |
| Access controls | System access limited to authorized individuals, with authority checks. | Software provides; you configure roles correctly. |
| E-signatures | Signature includes signer name, date/time, meaning; linked to the record, non-transferable. | Software provides; you operate per SOP. |
| Record retention | Accurate copies + retrieval throughout the retention period. | Shared — software stores; you set retention policy. |
| Procedures (SOPs) | Documented procedures governing use, training, and accountability. | YOU — entirely your responsibility. |
What we'd tell a life-sciences operator shopping "Part 11 software."
Buy software for the capability, not the compliance promise — and budget the validation as the real cost. The pattern that burns regulated teams: a vendor demo says "fully 21 CFR Part 11 compliant," the team buys it, ships it, and an FDA inspection later finds the audit trail wasn't fully enabled, the validation was thin, or the SOPs didn't exist. The software was *capable*; the implementation wasn't *compliant*. The FDA doesn't audit the vendor — it audits you.
So evaluate vendors on whether they make YOUR validation easier — pre-written validation documentation, IQ/OQ/PQ templates, a documented audit-trail spec — not on whether they say the magic words "Part 11 compliant." A system that's technically capable but gives you no validation support can cost more in CSV labor than a slightly pricier one that hands you the validation package.
And remember the controls overlap with the rest of your stack. Audit trails, access control, and change management feed Part 11, SOC 2, and HIPAA alike — build them once and map them to each regime. If you're a San Diego life-sciences operator figuring out which frameworks you even trigger, start with the biotech & life-sciences compliance map. Want a straight read on whether a system you're evaluating actually eases your validation burden? Text PJ — no retainer.
What regulated-software buyers Google before they sign.
It's software built to support the FDA's 21 CFR Part 11 requirements for electronic records and electronic signatures in regulated (drug, device, biologic) activities. In practice that means the system provides: secure, time-stamped, computer-generated audit trails; role-based access controls; electronic-signature controls that bind the signature to the record with the signer's name, date/time, and meaning; record retention and retrieval; and operational/authority checks. Categories include eTMF, LIMS, eQMS, CTMS, and manufacturing execution systems. But "Part 11 software" provides the capabilities — it doesn't make you compliant by itself.
No — and this is the costliest misunderstanding in regulated software. A vendor can build a system that is Part 11 CAPABLE (it has the audit trails, access controls, and e-signature features), but compliance is a property of how YOU validate, configure, and operate it in your environment. The FDA holds the regulated company accountable, not the vendor. You still need Computer System Validation (CSV), documented procedures (SOPs) for use, and evidence the controls are turned on and working. "Part 11 compliant software" is shorthand for "Part 11 capable" — the validation and configuration are yours.
Any computer system that creates, modifies, maintains, archives, retrieves, or transmits records required by an FDA predicate rule — or that the FDA may inspect. Common ones in life sciences: electronic Trial Master File (eTMF), Laboratory Information Management Systems (LIMS), electronic Quality Management Systems (eQMS), Clinical Trial Management Systems (CTMS), Manufacturing Execution Systems (MES), and electronic batch records. If a system holds GxP-regulated data or e-signatures tied to regulated activities, Part 11 applies. General business software that never touches regulated records typically does not.
The core controls: (1) validation of systems to ensure accuracy, reliability, and consistent intended performance; (2) secure, computer-generated, time-stamped audit trails that record who did what and when, without obscuring prior entries; (3) access controls limiting system access to authorized individuals; (4) electronic signatures that include the signer's printed name, date/time, and the meaning of the signing, and that are linked to their records so they can't be copied or transferred; (5) operational and authority checks; and (6) controls over record copies and retention. Validation (CSV) and the audit trail are where most findings happen.
Part 11 is FDA regulatory compliance for data integrity and e-signatures in regulated activities; SOC 2 is a commercial security attestation that builds customer trust. They overlap on technical controls — access control, audit trails, change management — but serve different masters: the FDA versus your enterprise customers. A drug-development company needs Part 11 regardless of SOC 2; a life-sciences SaaS selling to pharma needs SOC 2 regardless of Part 11. Many life-sciences operators need both, and the shared controls mean doing one builds toward the other. See our biotech compliance map for how they sequence.